Stocks · Health care · Pharmaceutical Preparations

Contineum Therapeutics, Inc.

CTNM Clue Score32
United States Fiscal year ends December CIK 0001855175 Results filed 3 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Stephen L. Huhn
13 Aug 2024
CMO & Sr VP, Clinical Dev.
Exercised, kept
12,800
$1.01
$12.93K

What was left out

Form 4 filings counted 63
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 21
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 644,767
History held since 11 Apr 2024